171 related articles for article (PubMed ID: 36096033)
1. Optimal cytoreduction followed by chemoradiation in stage IVB uterine serous carcinoma.
McEachron J; Zhou N; Hastings V; Bennett M; Gorelick C; Kanis MJ; Lee YC
Cancer Treat Res Commun; 2022; 33():100631. PubMed ID: 36096033
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen.
Lee LJ; Demaria R; Berkowitz R; Matulonis U; Viswanathan AN
Gynecol Oncol; 2014 Jan; 132(1):65-9. PubMed ID: 24211401
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinoma.
Wilkinson-Ryan I; Frolova AI; Liu J; Stewart Massad L; Thaker PH; Powell MA; Mutch DG; Hagemann AR
Int J Gynecol Cancer; 2015 Jan; 25(1):63-8. PubMed ID: 25365590
[TBL] [Abstract][Full Text] [Related]
4. Uterine serous carcinoma: role of surgery, risk factors and oncologic outcomes. Experience of a tertiary center.
Ditto A; Leone Roberti Maggiore U; Lopez S; Martinelli F; Bogani G; Lo Vullo S; Brusadelli C; Paolini B; Ducceschi M; Mantiero M; Chiappa V; Signorelli M; Evangelista M; Mariani L; Raspagliesi F
Eur J Surg Oncol; 2022 Jan; 48(1):268-274. PubMed ID: 34753617
[TBL] [Abstract][Full Text] [Related]
5. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
6. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K; Kucukali T
Int J Gynecol Cancer; 2002; 12(5):448-53. PubMed ID: 12366661
[TBL] [Abstract][Full Text] [Related]
7. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival.
Bristow RE; Zerbe MJ; Rosenshein NB; Grumbine FC; Montz FJ
Gynecol Oncol; 2000 Aug; 78(2):85-91. PubMed ID: 10926785
[TBL] [Abstract][Full Text] [Related]
8. The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish study.
Cakir C; Kilic F; Kilic C; Tokgozoglu N; Ersak B; Ayhan S; Akar S; Yuksel D; Korkmaz V; Boran N; Toptas T; Kimyon Comert G; Ureyen I; Tasci T; Turkmen O; Moraloglu Tekin O; Ustun Y; Turan T
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102063. PubMed ID: 33453448
[TBL] [Abstract][Full Text] [Related]
9. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study.
Alagkiozidis I; Grossman A; Tang NZ; Weedon J; Mize B; Salame G; Lee YC; Abulafia O
Int J Surg; 2015 Feb; 14():61-6. PubMed ID: 25576762
[TBL] [Abstract][Full Text] [Related]
10. Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma.
McEachron J; Heyman T; Shanahan L; Tran V; Friedman M; Gorelick C; Economos K; Singhal PK; Lee YC; Kanis MJ
Int J Gynecol Cancer; 2020 Jul; 30(7):1012-1017. PubMed ID: 32447295
[TBL] [Abstract][Full Text] [Related]
11. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.
Bristow RE; Duska LR; Montz FJ
Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the optimal sequence of adjuvant chemotherapy and radiation therapy in the treatment of advanced endometrial cancer.
McEachron J; Zhou N; Spencer C; Shanahan L; Chatterton C; Singhal P; Lee YC
J Gynecol Oncol; 2020 Nov; 31(6):e90. PubMed ID: 33078595
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study.
Unsal M; Kilic C; Cakir C; Kilic F; Ersak B; Karakas S; Tokgozoglu N; Varli B; Oktar O; Kimyon Comert G; Ozdemir IA; Boran N; Toptas T; Ureyen I; Korkmaz V; Taskin S; Moraloglu Tekin O; Ustun Y; Tasci T; Ortac F; Turan T
J Obstet Gynaecol; 2023 Dec; 43(1):2151355. PubMed ID: 36503383
[TBL] [Abstract][Full Text] [Related]
14. Improved survival with combination chemotherapy and external beam radiation therapy in uterine carcinosarcoma.
McEachron J; Chen YJ; Zhou N; Kao J; Gorelick C; Kanis MJ; Lee YC
Int J Gynecol Cancer; 2022 Nov; 32(11):1402-1409. PubMed ID: 36343971
[TBL] [Abstract][Full Text] [Related]
15. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma.
Rauh-Hain JA; Growdon WB; Schorge JO; Goodman AK; Boruta DM; McCann C; Horowitz NS; del Carmen MG
Gynecol Oncol; 2010 Nov; 119(2):299-304. PubMed ID: 20691465
[TBL] [Abstract][Full Text] [Related]
16. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
17. Potential risk factors associated with prognosis of neoadjuvant chemotherapy followed by interval debulking surgery in stage IIIc-IV high-grade serous ovarian carcinoma patients.
Zhang J; Liu N; Zhang A; Bao X
J Obstet Gynaecol Res; 2018 Sep; 44(9):1808-1816. PubMed ID: 30019801
[TBL] [Abstract][Full Text] [Related]
18. Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy.
Tortorella L; Langstraat CL; Weaver AL; McGree ME; Bakkum-Gamez JN; Dowdy SC; Cliby WA; Keeney GL; Sherman ME; Weroha SJ; Mariani A; Podratz KC
Gynecol Oncol; 2018 May; 149(2):291-296. PubMed ID: 29550183
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
[No Abstract] [Full Text] [Related]
20. Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery.
Nasioudis D; Wang X; Dhillon G; Latif N; Ko EM; Giuntoli RL; Gershenson D; Fader A; Carey M; Simpkins F
Int J Gynecol Cancer; 2023 Dec; 33(12):1906-1912. PubMed ID: 37879909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
